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Abstract Coaxial electrospraying was explored to organize polymer excipients in a core-shell 43 
manner for providing biphasic controlled release of active ingredient. With ferulic acid (FA) as a 44 
model drug, and shellac and polyvinylpyrrolidone as the core and shell polymeric matrices, 45 
core-shell nanoparticles were successfully fabricated. A series of tests were carried out to 46 
characterize the prepared core-shell nanoparticles and also the nanoparticles prepared using a 47 
single fluid electrospraying of the shell or core fluids alone. The core-shell nanoparticles had an 48 
average diameter of 530 ± 80 nm with clear core-shell structure. The contained FA was converted 49 
to an amorphous state both in the core and the shell parts due to the favorable hydrogen bonding 50 
between the components. In vitro dissolution tests demonstrated that the core-shell nanoparticles 51 
were able to provide the desired biphasic drug controlled release profiles. Coaxial electrospraying 52 
is a useful tool for the development of novel nano drug delivery systems from polymers.   53 
Keywords Coaxial electrospraying; Core-shell nanopartciles; Shellac; Bipahsic controlled release; 54 
Structural nanocomposites  55 
 56 
Introduction  57 
Nanosizing strategies have exerted great influence on the development of novel drug delivery 58 
systems (DDS) [1,2]. Today, as the progress of nanotechnology, more and more attention has been 59 
paid to the fabrication of nanostructures, by which improved or even new functional performances 60 
can be achieved [3]. One of the most popular and simple nanostructures is the core-shell structure 61 
(with different exterior and interior) [4], and many complicated structures are essentially the 62 
derivatives of this structure, such as making holes in the shell or encapsulating even smaller 63 
nanoparticles in the core.  64 































































Because of the usefulness of this structure in tailoring the functions of the products, a wide 65 
variety of methods have been reported for the fabrication of core-shell products, such as 66 
core-sheath nanofibers and core-shell nanoparticles [5, 6]. It is a common sense that the bottom-up 67 
approaches are more suitable than top-down approaches for the synthesis of core-shell 68 
nanostructures [7]. However, coaxial electrohydrodynamic atomization processes (EHDA, 69 
including electrospinning, electrospraying and e-jet printing) have successfully been used to 70 
generate core-shell nanostructures in a top-down manner, for instance in the preparation of 71 
core-sheath nanofibers by electrospinning [8, 9]. Compared with some bottom-up chemical 72 
methods which are often multiple-step, time-consuming, coaxial electrospraying is able to 73 
generate core-shell nanoparticles in a single step and straightforwardly [10].  74 
Based on the fact that liquids can readily interact with electrical energy, EHDA processes are 75 
developed for preparing nano products through the fast removing of organic solvents employing 76 
electrical energy directly [11-13]. The fast drying electrospinning process not only can propagate 77 
the physical state of the components in the liquid solutions into the solid nanofibers, but also can 78 
duplicate the concentric structure of the spinneret on a macroscale to products on a nanoscale. 79 
Thus, the components in the sheath and core fluids often occur in the sheath and core parts of the 80 
nanofibers, respectively, with little diffusion [14]. Similarly, coaxial electrospraying has been 81 
proved to be a powerful tool for generating core-shell micro-/nano-particles, and also hollow 82 
microspheres from the concentric fluids based on the templates of a concentric spray head [15-17].    83 
Biphasic drug controlled release is a special release type that obeys biological rhythm for safe 84 
and effective drug delivery and convenient administration [18]. An initial rapid release of a 85 
fraction of the dose after administration is in favor of relieving the symptoms of the disease, and 86 































































later a sustained release of the remaining dose over a defined period can optimize the therapy and 87 
avoid repeated administration for the patients’ convenience [19]. Many traditional pharmaceutical 88 
methods and also the emerged advanced techniques have been exploited in literature to produce 89 
novel materials or DDS for furnishing biphasic release, taking its advantage in a more accurate 90 
time-programmed administration of active ingredients and fulfilling the specific therapeutic needs 91 
of some diseases. [20].  92 
Over the past several decades, polymer science has acted as the backbone for supporting the 93 
development of pharmaceutics, particularly in the area of controlled release [21]. Because of their 94 
relative abundance, low cost, and bio-degradable and eco-friendly profiles, natural polymeric 95 
materials has drawn increasing attention and interest as potential pharmaceutical excipients [22]. 96 
Shellac is the purified product of the natural material Lac which is secreted by the small parasitic 97 
insect Kerria Lacca on various host trees in South Eastern Asia. It has properties of water 98 
resistance, biocompatibility and fine membrane forming ability. Shellac has found its applications 99 
in agriculture, food products, and DDS as the only pharmaceutically used resin of animal origin 100 
[23]. The dissolution behavior of shellac may be of interest for sustained release or colon targeting 101 
applications, particularly in the drug formations of traditional coating way [24].  102 
Building on the above-mentioned knowledge, this study investigated the preparation of 103 
drug-loaded core-shell nanoparticles using a coaxial electrospraying process for providing a 104 
biphasic drug controlled release profile. Shellac and polyvinylpyrrolidone (PVP) were exploited as 105 
the core and shell polymeric matrices, respectively. PVP has a wide variety of applications in 106 
pharmaceutics, medicine and cosmetics [25,26]. Ferulic acid (FA), 4-hydroxy-3-methoxycinnamic 107 
acid, was explored as a drug model. It is an antioxidant that is able to neutralize free radicals 108 































































(superoxide, nitric oxide and hydroxyl radical), which can cause oxidative damage to cell 109 
membranes and DNA. Studies have shown that FA can decrease blood glucose levels and so could 110 
be applicable for the treatment of diabetes patients and it can also reduce the risk of many cancers, 111 
including cancer of the stomach, breast, colon, liver, prostate, lung and tongue [27, 28].  112 
Experimental 113 
Materials  FA was purchased from Shanghai Winherb Medical Sci & Tech Development Co., 114 
Ltd (Shanghai, China). PVP K25 (Mw = 30,000) was purchased from the Sigma-Aldrich Co. Ltd. 115 
(Shanghai, China). Shellac (purity of 95%, wax free) was supplied by the ShengHui Agricultural 116 
science and Technology Co., Ltd. (Yunnan, China). Sodium hydrate, hydrochloric acid and 117 
anhydrous ethanol were provided by the Shanghai Shiyi Chemical Reagent Co., Ltd. (Shanghai, 118 
China). All chemicals used were analytical grade. Water was double distilled just before use.  119 
Coaxial electrospraying  A mixed solution of 5% (w/v) PVP and 1% (w/v) FA in ethanol was 120 
prepared as the shell fluid. The core solution consisted of 10% (w/v) shellac and 1% (w/v) FA in 121 
ethanol. A homemade concentric spinneret was used to carry out coaxial electrospraying. Two 122 
syringe pumps (KDS 100 and KDS 200, Cole-Parmer, Vernon Hills, IL, USA) were employed to 123 
drive the shell and core fluids. A high voltage supply (ZGF 60kV / 2 mA, Shanghai Sute Electrical 124 
Co., Ltd, Shanghai, China) provided an   applied voltage below 60 kV. All electrospraying 125 
processes were carried out under ambient conditions (27 °C ± 2 °C with relative humidity 51% ± 126 
7%). The resultant nanoparticles were collected on a metal collector wrapped with aluminum foil 127 
at a fixed distance of 10 cm from the needle tip of the spray head. Experiments were recorded 128 
using a digital video recorder (PowerShot A640, Canon, Japan) under 11 × magnifications. The 129 
nanoparticles were stored in a desiccator before characterization was undertaken. Details of the 130 































































parameters for electrospraying and the resultant products are listed in Table 1. 131 
Characterization 132 
Morphology and structure  The morphologies of the core-shell nanoparticles were assessed 133 
using an S-4800 field emission scanning electron microscope (FESEM, Hitachi, Tokyo, Japan). 134 
Their average sizes were determined by measuring the diameters of more than 100 particles in 135 
FESEM images using the Image J software (National Institutes of Health, Bethesda, MD, USA). 136 
The topographies of raw PVP and FA were observed under cross-polarized light using an XP-700 137 
polarized optical microscope (Shanghai Changfang Optical Instrument Co. Ltd, Shanghai, China) 138 
and crude shellac was observed using the PowerShot A640 digital video recorder. Transmission 139 
electron microscopy (TEM) images of nanoparticles N3 were taken on a JEM 2100F 140 
ﬁeld-emission transmission electron microscope (JEOL, Tokyo, Japan). TEM samples were 141 
prepared by fixing a lacey carbon coated copper grid on the metal collector and nanoparticles 142 
sprayed directly onto the grid. 143 
Physical status of the components   X-ray diffraction (XRD) was performed on a D/Max-BR 144 
diffractometer (RigaKu, Tokyo, Japan) over the 2θ range of 5–60° using Cu Kα radiation at 40 145 
mV and 30 mA. Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectra were 146 
recorded on a Nicolet-Nexus 670 FTIR spectrometer (Nicolet Instrument Corporation, Madison, 147 
WI, USA) over the range 500-4000 cm-1 and at a resolution of 2 cm−1. Approximately 5 mg of the 148 
materials were placed directly on the diamond window for spectra acquisition.  149 
In vitro dissolution   In vitro dissolution tests were carried out according to the Chinese 150 
Pharmacopoeia (2010 Ed.). Dissolution studies were undertaken following Method II, a paddle 151 
method, using a RCZ-8A apparatus (Tianjin University Radio Factory, Tianjin, China). 200 mg 152 































































samples of N1, N2 and N3 were first placed in 600 mL of 0.01N HCl for 2 h, and later 0.24 g 153 
sodium hydrate was added to the dissolution medium to adjust its pH value to 7.0. The 154 
temperature of the dissolution medium was fixed at 37 ± 1 °C and the instrument was set to stir at 155 
50 rpm. At predetermined time points, aliquots of 5.0 mL were withdrawn from the dissolution 156 
medium and replaced with fresh medium to maintain a constant volume. After filtration through a 157 
0.22 µm membrane (Millipore, MA, USA) and appropriate dilution with phosphate buffer (PBS, 158 
pH7.0, 0.1M), samples were analyzed at λmax =322 nm using a UV–vis spectrophotometer 159 
(UV-2102PC, Unico Instrument Co. Ltd., Shanghai, China). The cumulative amount of FA 160 
released at each time point was back-calculated from the data obtained against a predetermined 161 
calibration curve. Experiments were carried out six times and results are reported as mean values 162 
± S.D. 163 
Results and discussion 164 
Coaxial electrospraying   A schematic diagram of the coaxial electrospraying process is shown 165 
in Fig. 1a. A typical electrospraying system consists of four major components: one or more 166 
syringe pumps, a power supply, a spray head and a collector, by which the electrical energy is 167 
directly exploited to dry and solidify micro-fluid jets, causing solvent evaporation and producing 168 
micro-/nano- size products effectively. During the electrospraying process, a liquid is fed to a 169 
metal capillary at the end of which a droplet is formed. When the droplet is exposed to a strong 170 
electrical field, a charge is induced on its surface. Provided the liquid has sufficient electrical 171 
conductivity, there will be a range of combinations of the liquid flow rate and the applied voltage 172 
for which the drop will assume a conical shape (the Taylor cone). At the apex of this cone, a 173 
narrow jet is formed (cone-jet mode) which subsequently breaks up into fine droplets (Fig. 1b). 174 































































Electrospraying first generates near-monodisperse droplets whose size can be varied between a 175 
few to hundreds of micrometers. Later, the droplets rapidly shrink due to the fast evaporation of 176 
solvents resulting from the Coulombic explosion. The huge surface areas of the micro-droplets 177 
provide the possibility for complete of the solvents and the solidification of products. The facile 178 
interactions of electrons with fluid solvents accelerate their evaporation [29]. The electrons always 179 
accumulate on the surface of droplets and result in the fast fission to bring a Coulombic explosion 180 
(i.e. atomization). Thus during the coaxial electrospraying processes, the outer shell fluids can 181 
dominate the splitting of droplets step-by-step, and by which the next level of droplets also have 182 
the core-shell structures until the formation of solid core-shell nanoparticles (Fig. 1b).  183 
The arrangement of the apparatus used in this work is shown in Fig. 2a. The inset of Fig. 2a 184 
shows a digital picture of the home-made concentric spray head, which consists of two stainless 185 
steel capillaries, with the smaller one (27G, , the outer and inner diameters are 1.25 and 0.84, 186 
respectively) penetrated through the larger one (18G, the outer and inner diameters are 0.42 and 187 
0.21, respectively) to form a concentric structure. The inner capillary projected a length of 0.2 mm 188 
out of the outer capillary for avoiding possible mixing. An alligator clip was used to connect the 189 
spray head with the power supply (Fig. 2b).  190 
After some optimization, a fixed high voltage of 20 kV was applied. A typical coaxial 191 
electrospraying process was exhibited in Fig. 2c, which was taken under a same shell and core 192 
fluid flow rate of 0.2 mL/h. A short straight thinning jet is emitted from the compound Taylor cone 193 
(Fig. 2c and 2d) and is followed by the explosion atomization region. The core fluid showed dark 194 
brown color due to the dissolution of shellac and the shell fluid can be discerned by the visible 195 
inner capillary in Fig. 2d. The Taylor cone exhibited a triangle with straight line, while the Taylor 196 































































cone of the electrospinning always shows a camber line due to high surface tensions of 197 
electrospinnable solutions [19]. When one of the shell or core fluid flow rates was adjusted to 0 198 
mL/h, then a single fluid electrospraying could be implemented for the preparation of 199 
nanoparticles N1 and N2.     200 
Morphology and structure   Single fluid electrospraying of the shell and core fluid alone 201 
resulted in solid products of the nanoparticles N1 and N2 (Table 1 and Fig. 3a and b). They have 202 
an average diameter of 470 ± 110 nm (Fig. 3a) and 720 ± 180 nm (Fig. 3b), respectively. With 203 
core and shell flow rates were controlled at 0.2 mL/h, the core-shell nanoparticles N3 were 204 
generated, which had an average diameter of 530 ± 80 nm (Fig. 3c and 3d). The insets of Fig. 3a, b 205 
and d showed that nanoparticles N2 and N3 were compact and spherical nanoparticles, whereas 206 
nanoparticles N1 were somewhat flat with depressions. All the three types of nanoparticles had a 207 
few satellites on the surface.  208 
Fig. 4 shows the TEM images of the coaxial electrosprayed nanoparticles N3. They have 209 
clear core-shell structures, with the cores a darker gray color because of the presence of shellac. 210 
There is uniform gray shading in both the shell and core parts of the microparticles in all the 211 
images, indicating that FA is uniformly distributed in the PVP matrix of the shell part, and also in 212 
the shellac matrix of the core part. The satellites had a similar gray level of the shell part, 213 
suggesting that they were fabricated by the fission of the shell fluid during the coaxial 214 
electrospraying process.    215 
Physical status and compability  216 
The crude FA exists as crystalline materials, which is demonstrated by the observation of 217 
colorful images when their particles are viewed under polarized light (Fig. 5a). In contrast to the 218 































































observations of FA under polarized light, the images of PVP powders show no bright colors, 219 
suggesting it is amorphous (Fig. 5b). Shellac exists as reddish-brown platelets, as shown by the 220 
digital picture in Fig. 5c. The physical status of the components and nanoparticles were further 221 
investigated using XRD. The presence of distinct peaks in the XRD patterns of the FA raw 222 
particles indicated that FA was present as crystalline material with characteristic diffraction peaks 223 
(Fig. 5d). No distinct peaks in the spectrum of PVP and shellac evidently indicated that the 224 
molecular orientation and arrangement of the polymers were disordered, i.e. an amorphous state. 225 
Similarly, there were no discrete peaks in the spectrum of nanoparticles N1, N2 and N3, which 226 
implied that the original crystalline FA was no longer present as crystalline material, but had been 227 
converted into an amorphous state, no matter it is in the core part or in the shell part (Fig. 5d). The 228 
solubility behavior of poorly water-soluble drugs is one of the most challenging aspects of the 229 
formulation development in pharmaceutics [30]. It is desirable if the process can alter the physical 230 
status of drug to the favorable nanocrystalline, amorphous or solid solution phases for effective 231 
drug delivery. Here, the coaxial electrospraying process exhibited its capability of generating 232 
amorphous structural nanomaterials of poorly water-soluble drug.  233 
ATR-FTIR was conducted to investigate the compatibility between the active ingredients and 234 
the polymeric matrices in the nanoparticles. Compared to the spectra of pure FA and shellac, there 235 
are significant changes in the spectra of the nanoparticles (Fig. 6), including (1) the characteristic 236 
peaks of the carbonyl groups (C=O stretch vibration) at 1714 cm-1 in shellac spectra shifting to 237 
1698 cm-1 in nanoparticles N2 and to 1702 cm-1 in Nanoparticles N3. Similarly, the characteristic 238 
peaks of the carbonyl groups (C=O stretch vibration) at 1660 cm-1 in PVP spectra shifting to 1654 239 
cm-1 in nanoparticles N1, and 1656 cm-1 in Nanoparticles N3 ; (2) the decrease or even 240 































































disappearance of the numerous peaks in the finger region of FA in all the three types of 241 
nanoparticles; (3) the characteristic peaks of the carbonyl groups (C=O stretch vibration) at 1663 242 
and 1689 cm-1 of FA melting into the 1654 cm-1 in nanoparticles N1, 1698 cm-1 in nanoparticles 243 
N2, and 1656 cm-1 and 1702 cm-1 in nanoparticles N3. All these changes can be attributed to 244 
hydrogen bonding between FA and shellac, and between FA and PVP, including (1) between C=O 245 
of FA and O-H of shellac, and (2) between the C=O of shellac/PVP and the O-H of FA, as clearly 246 
shown in the molecular formula (Fig. 6). All these secondary interactions would avail to the 247 
formation of FA-PVP nanocomposites in nanoparticles N1 and the shell part of nanoparticles N3, 248 
and the formation of FA-shellac nanocomposites in nanoparticles N2 and the core part of 249 
nanoparticles N3. Thus the nanoparticles were essentially a structural nanocomposite.  250 
Functional performance and controlled-release mechanism  The in vitro drug release profiles 251 
of the three nanoparticles are given in Fig. 7a and 7b. The nanoparticles N1 disappeared instantly 252 
when they were put into the acidic dissolution medium. In vitro dissolution tests verified that all 253 
the FA was dissolved into the bulk media in the first hour. This result is attributed to the 254 
hydrophilic properties of PVP, large surface areas of the nanoparticles, and the amorphous status 255 
of FA in the nanocomposites, which made the FA molecules can dissolve simultaneously with PVP 256 
molecules through erosion mechanism.  257 
The nanoparticles N2 released only 1.7% of the incorporated FA during 1 h immersion in the 258 
acid dissolution medium. This resulted from the insolubility of shellac in low pH environments. 259 
After the dissolution environment was changed to a neutral condition, nanopartciles N2 released 260 
the embedded FA over around 9 h in a sustained manner. The nanoparticles N3 evidently exhibited 261 
a combination of the release profiles of nanoparticles N1 and N2 with the shell part providing an 262 































































initial rapid release and the core part furnishing a sustained release.  263 
A suggested mechanism is put forward in Fig. 7c. Based on the different dissolution 264 
properties of the polymeric excipients, and intentional arrangement of them into the core-shell 265 
nanostructure, a structure-activity relationship at nanoscale can be achieved. The release of the 266 
encapsulated drug in the core-shell nanoparticles can be manipulated step-by-step through the 267 
gradual dissolutions of the layered polymer matrices in different environments. In the present 268 
biphasic release profiles provided by nanoparticles N3, 51.2% of the contained drug was freed 269 
during the first phase, and the remnant released in a sustained manner. Certainly, the release 270 
content in the two phases can be easily tuned simply through the adjustment of drug content in the 271 
shell or core fluids during the preparation of the core-shell nanoparticles. Further in vivo 272 
experiments will be conducted to investigate the medicinal effects of the nanoparticles N3.  273 
Conclusions 274 
    Core-shell nanoparticles were successfully fabricated using a coaxial electrospraying process. 275 
FESEM and TEM images demonstrated that the core-shell nanoparticles had an average diameter 276 
of 530 ± 80 nm with clear core-shell structure. XRD and polarized microscopy showed that the 277 
contained FA was converted to an amorphous state both in the core and the shell parts due to the 278 
favorable hydrogen bonding between the components, as verified by the ATR-FTIR spectra. In 279 
vitro dissolution tests demonstrated that the core-shell nanoparticles could combine the drug 280 
release profiles provided by the nanoparticles prepared from the shell or core fluid alone through a 281 
single fluid electrospraying, providing the designed biphasic drug release profiles. Coaxial 282 
electrospraying is a powerful tool for generating core-shell nanostructures with tailored 283 
components and compositions, and thus to realize a structure-activity relationship at nanoscale.  284 
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Table and Figure Caption 360 
 361 
Table 1 Parameters used for electrospraying and details of the nanoparticulate products  362 
Fig. 1 Coaxial electrospraying: (a) a schematic diagram of the coaxial electrospraying process; (b) 363 
a diagram of the atomization mechanism    364 
Fig. 2 Implementation of the coaxial electrospraying process. a) the arrangement of the apparatus 365 
used in this work (the inset Image is the nozzle of the concentric spray head); b) the connection of 366 
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Table 1 Parameters used for electrospraying and details of the nanoparticulate products  398 
 399 
 400 
a The shell fluid consisted of 5% (w/v) PVP K25 and 1% (w/v) FA in ethanol. 401 





Flow rate (mL/h) 
Morphology 
Diameter 
(nm) Shell fluid a Core fluid b 
N1 Single fluid 0.4 -- Nanoparticles 470 ± 110 
N2 Single fluid -- 0.4 Nanoparticles 720 ± 180 
N3 Coaxial 0.2 0.2 Nanoparticles 530 ± 80 

































































Fig. 1 Coaxial electrospraying: (a) a schematic diagram of the coaxial electrospraying process; (b) a 
diagram of the atomization mechanism  
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Fig. 2 Implementation of the coaxial electrospraying process. a) the arrangement of the apparatus used in 
this work (the inset Image is the nozzle of the concentric spray head); b) the connection of the spray head 
with the power supply using an alligator clip; c) a typical coaxial electrospraying process under an applied 
voltage of 20 kV, with a same shell and core fluid flow rates of 0.2 mL/h; d) the compound Taylor cone  
60x56mm (300 x 300 DPI)  
 
 

































































Fig. 3 FESEM images of the nanoparticles, and their diameter distributions, (a) nanoparticles N1, (b) 
nanoparticles N2, (c) and (d) nanoparticles N3 with different magnifications    
60x51mm (300 x 300 DPI)  
 
 

































































Fig. 4 TEM images of nanoparticles N3  
70x48mm (300 x 300 DPI)  
 
 

































































Fig. 5 XRD patterns and observations of the crude particles. a) microscopy images viewed under cross-
polarized light: a) FA; b) PVP; c) a digital image of shellac; d) XRD patterns of the starting materials and 
nanoparticles N1, N2, and N3  
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Fig. 6 ATR-FTIR spectra of the raw materials and nanoparticles, and the molecular structures of PVP, FA and 
shellac  
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Fig. 7 In vitro dissolution tests. a) in vitro FA release profiles during the whole time period (n=6); b) in vitro 
FA release profiles of the first hour (n=6); c) a schematic about the drug controlled release mechanisms 
from the core-shell nanoparticles  
80x56mm (300 x 300 DPI)  
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